Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Burlew

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Cardiology|November 1, 1990
Managing the pregnant patient with heart diseaseB S Burlew
Cardiology Clinics|September 15, 2000
Connective tissue and the heart. Functional significance and regulatory mechanismsB S Burlew, K T Weber
Pharmacotherapy|December 17, 1997
Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and responseK M Sowinski, B S Burlew
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1996
Metoprolol metabolism via cytochrome P4502D6 in ethnic populationsJ A Johnson, B S Burlew
Clinical Pharmacology and Therapeutics|May 1, 1992
Racial differences in propranolol pharmacokineticsJ A Johnson, B S Burlew
Clinical Pharmacology and Therapeutics|June 1, 1995
Racial differences in sensitivity to the negative chronotropic effects of propranolol in healthy menK M Sowinski, B S Burlew, J A Johnson
Journal of Neuroscience Methods|March 1, 1982
Rapid freezing of neural tissues for electron microscopy: a specimen carrier for correlative electrophysiological studiesJ J Pysh, G K Florek, B S Burlew
Journal of Cardiovascular Pharmacology|January 1, 1995
Racial differences in beta-adrenoceptor-mediated responsivenessJ A Johnson, B S Burlew, R N Stiles
Cell Transplantation|February 24, 2001
Sustained improvements in cardiac geometry and function following kidney-pancreas transplantationA O Gaber, M N Wicks, D K Hathaway, et al.
American Heart Journal|October 1, 1987
Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failureB S Burlew, M Gheorghiade, S M Jafri, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Cardiology|November 1, 1990
Managing the pregnant patient with heart diseaseB S Burlew
Cardiology Clinics|September 15, 2000
Connective tissue and the heart. Functional significance and regulatory mechanismsB S Burlew, K T Weber
Pharmacotherapy|December 17, 1997
Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and responseK M Sowinski, B S Burlew
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1996
Metoprolol metabolism via cytochrome P4502D6 in ethnic populationsJ A Johnson, B S Burlew
Clinical Pharmacology and Therapeutics|May 1, 1992
Racial differences in propranolol pharmacokineticsJ A Johnson, B S Burlew
Clinical Pharmacology and Therapeutics|June 1, 1995
Racial differences in sensitivity to the negative chronotropic effects of propranolol in healthy menK M Sowinski, B S Burlew, J A Johnson
Journal of Neuroscience Methods|March 1, 1982
Rapid freezing of neural tissues for electron microscopy: a specimen carrier for correlative electrophysiological studiesJ J Pysh, G K Florek, B S Burlew
Journal of Cardiovascular Pharmacology|January 1, 1995
Racial differences in beta-adrenoceptor-mediated responsivenessJ A Johnson, B S Burlew, R N Stiles
Cell Transplantation|February 24, 2001
Sustained improvements in cardiac geometry and function following kidney-pancreas transplantationA O Gaber, M N Wicks, D K Hathaway, et al.
American Heart Journal|October 1, 1987
Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failureB S Burlew, M Gheorghiade, S M Jafri, et al.
Pageof 2